History is augmentation on end-The Surprisingly Weird History Of Breast Implants

Please join the Simons Foundation and our generous member organizations in supporting arXiv during our giving campaign September Help Advanced Search. Donate to arXiv Please join the Simons Foundation and our generous member organizations in supporting arXiv during our giving campaign September We gratefully acknowledge support from the Simons Foundation and member institutions. Subjects: Computation and Language cs.

History is augmentation on end

History is augmentation on end

This approach is particular interesting because it allows History is augmentation on end application of human ingenuity from large numbers of people and companies. Table 1 A table showing the individually reported incidence rates for capsular contracture following implant based breast augmentation surgery. The coin itself was used as an AR trigger, and when held in front of an AR-enabled device it revealed additional objects and layers of information that were not visible without the device. Yes Really. To search the entire text of ed book, type in your search term here and press Enter. Once located, the operator could more efficiently direct rescuers to the hiker's location because the geographic position and reference landmarks were clearly labeled.


If you'd love to use one of my posts in your newsletter, blog or website - you have my permission Histoory one condition! The contemporary models augmenttation saline breast implant augmentatiin manufactured with thicker, room-temperature vulcanized RTV shells History is augmentation on end of Hisgory silicone elastomer. In fat-graft breast augmentation procedures, there is the risk that the adipocyte tissue grafted to the breast s can undergo necrosismetastatic calcificationdevelop cysts, and agglomerate into palpable lumps. The balloon inflates with the onset of diastole, which corresponds with the middle of the T-wave. Nevertheless, a contoured abdomen for the patient is an additional benefit derived from the liposuction harvesting of the adipocyte tissue injected to the breasts. Carefully matching the type and size of the breast implants to the patient's pectoral soft-tissue characteristics reduces the incidence of revision surgery. Inthe Thai government endorsed a regimen of self-massage exercises as Prostate remove surgery alternative to surgical breast augmentation with breast implants. Modern Breast Implants The early s saw the beginning of the first implant technologies that were the direct precursors to the ones that are still in Histort today. I in covered multi-label image classification. By improving the haemodynamic condition of these patients, IABP can facilitate further percutaneous interventions or bridge the patient to surgery. The occurrence of such cosmetic problems is likelier in the case of History is augmentation on end woman with very little breast tissue, and in the case of the woman who requires post-mastectomy breast reconstruction; thus, the silicone-gel implant is Remove internal anal warts technically superior prosthetic device for breast augmentation, and for breast reconstruction. Categories : Cosmetic surgery Implants medicine Plastic surgical procedures Prosthetics Transgender and medicine Buttocks. This is not something we want to be doing by trial and error. Hey Adrain, I am fan your style, Now I have started following you through this blog.

At the height of summer, when London was baking in unseasonable heat, I made an ill-fated trip to the Serpentine lido in central London.

  • Breast augmentation and augmentation mammoplasty colloquially known as a " boob job" are plastic surgery terms for the breast-implant and the fat-graft mammoplasty approaches used to increase the size, change the shape, and alter the texture of the breasts of a woman.
  • The primary goal of intra-aortic balloon pump IABP treatment is to increase myocardial oxygen supply and decrease myocardial oxygen demand.
  • Knowing that I was going to write a tutorial on data augmentation, two weekends ago I decided to have some fun and purposely post a semi-trick question on my Twitter feed.
  • In most of our science fiction and our projections of the future, everything has changed—we have robots, flying cars, artificial intelligence, warp speed, laser swords--but we remain pretty much the same.
  • The one and only original breast augmentation blog on the web, written entirely by a breast implant patient and expert, Grace Gold.

In , more than , women and teenagers underwent surgery to have their breasts enlarged with silicone or saline implants and more than , breast cancer patients had reconstruction after mastectomy, often with implants. Many women are justifiably confused by the conflicting information they hear. Here are the facts about what is known and not known about the risks of breast implants. Breast implants made with silicone envelopes and filled with silicone gel or saline salt water were first sold in the United States in the s, but sales were relatively slow until the s.

By , however, almost one million women had undergone breast implant surgery, even though no safety studies had been published. Most of those women had silicone gel breast implants, which the plastic surgeons preferred.

Although most medical products must be proven safe and effective before they can be sold in the U. The Food and Drug Administration FDA did not require that companies selling silicone breast implants prove that their implants were safe until — after they had been in use for almost three decades.

For the first time, the media started to report about women with implant problems, and quoted doctors who were concerned about implant safety. The FDA did not require implant makers to prove that their saline implants were safe until , when, despite high complication rates, the FDA approved saline breast implants for the first time.

Silicone gel breast implants were approved for the first time in November Between and , silicone implants were restricted to clinical trials that were primarily for cancer patients and women with broken implants. The FDA required that patients be informed that the implants were not approved by the FDA and to be regularly evaluated by their plastic surgeons as part of the study, in order to provide safety data intended to help all women with gel implants.

Unfortunately, there was no enforcement of that requirement and women who were enrolled in these studies to enable them to get breast implants were often not studied after the surgery. There are still restrictions, however.

For example, they are only approved for women over the age of 22, because younger women are still developing physically and emotionally and probably would not fully understand the risks. Reports of complications among women with implants have been published in medical journals and discussed at public FDA meetings. There are a number of short-term and long-term risks that any woman thinking about getting breast implants or about removing or replacing older implants needs to be aware of.

Studies of saline breast implants and silicone gel breast implants conducted by implant manufacturers have shown that within the first three years, approximately three out of four reconstruction breast cancer patients and almost half of first-time augmentation patients experienced at least one local complication — such as pain, infection, hardening, or the need for additional surgery. Complication rates were lower, but still substantial, for augmentation patients.

The FDA has a consumer handbook with descriptions of common complications as well as photographs, available to consumers here.

Given the dramatic increase in diagnoses in recent years, it is clear that BIA-ALCL was under-diagnosed and under-reported for many years. In addition to the risks from anesthesia, surgical risks include infection and hematoma blood collecting around an implant , both of which can range from mild to severe.

Surgical risks are highest immediately around the time of surgery, but complications can require additional surgery later, which will have similar risks. A woman may need to face these surgical risks several times if she needs surgery to correct implant problems or has broken or damaged implants replaced with new ones.

Common local complications include loss of nipple sensitivity or painfully sensitive nipples. Problems like these can interfere with sexual intimacy.

Scar tissue that forms around any implant or foreign body can become hard or tight around the implant. This common problem is called capsular contracture. The scar tissue is inside the body, but it can cause the breasts to become very hard and misshaped, and it leads to discomfort that ranges from mild to severely painful. All breast implants will eventually break, but it is not known how many years the breast implants that are currently on the market will last.

Studies of silicone breast implants suggest that most implants last years, but some break during the first few months or years, while others last more than 15 years. In a study conducted by FDA scientists, most women had at least one broken implant within 11 years, and the likelihood of rupture increases every year.

Implant makers were required to study breakage and provide their studies to the FDA. Many women with silicone gel implants are unaware that their implants are broken or leaking.

Plastic surgeon Dr. Silicone Migration. Research has shown that silicone gel in implants can break down to liquid silicone at normal body temperatures, and there are reports of silicone leakage and migration from implants to the lymph nodes and other organs. A study published by the Royal Academy of Medicine in Scotland found that a woman with a broken silicone gel implant in her calf was coughing up silicone identical to the kind in her implant.

A more controversial question is whether breast implants cause diseases or illnesses, in addition to ALCL and problems in the breast area. Since these diseases may take many years to develop and be diagnosed, studies that include women who had implants for such a short time cannot be used to determine whether or not breast implants increase the long-term risks of getting these diseases. Studies conducted after those initial reports were published indicated that implants might be linked to a number of diseases.

Do implant patients who have autoimmune symptoms feel better if their implants are removed? A study of Danish women who had breast implants for an average of 19 years found that they were significantly more likely to report fatigue, Raynaud-like symptoms white fingers and toes when exposed to cold , and memory loss and other cognitive symptoms, compared to women of the same age in the general population. A report summarizing studies of breast implants was conducted by researchers hired by Tufts University and funded by The Plastic Surgery Foundation, which was supported by the 3 U.

This summary is notable for barely mentioning the studies quoted above. Other autoimmune and rare diseases were also significantly higher among women with Mentor silicone gel implants. These diagnoses were also statistically significantly higher for women with Allergan implants compared to the general population of women of similar demographics.

Given the large percentage of women who were not in the study for more than 1 year, it is not possible to know how representative these findings are. However, these results raise important questions, especially now that it is known that breast implants can cause cancer of the immune system. Cancers and Deaths. As mentioned above, breast implants can cause a type of cancer of the immune system called ALCL. There are also unanswered questions about cancer and implants.

More research is needed to draw any conclusions, however. There is no research evidence that implants cause breast cancer. However, implants can interfere with detection of breast cancer. Mammograms have been shown to detect breast cancer earlier, potentially saving lives as well as saving women from needed mastectomies.

There are several ways in which implants have the potential to delay detection of breast cancer:. Patients have reported that their implants delayed their breast cancer diagnosis. This is likely due to delays in breast cancer detection because of implants. A delay in diagnosis could result in the woman needing more radical surgery or the delay could be fatal.

A Canadian meta-analysis of five studies found that if women who had breast augmentation later developed breast cancer, they were more likely to die from it than women diagnosed with breast cancer who did not have breast augmentation. This increased risk of breast cancer-specific death is likely to be due to the greater inaccuracy of mammography for women with implants. An NCI study found that women who had breast implants for at least 12 years were more likely to die from brain tumors, lung cancer, other respiratory diseases, and suicide compared with other plastic surgery patients.

However, more research is needed to better control for relevant health habits. Three Scandinavian studies have reported that women who had breast implants for augmentation were three times more likely to commit suicide compared to women in the general population. According to the Institute of Medicine IOM , women with any kind of breast surgery, including breast implant surgery, are at least three times as likely to have an inadequate milk supply for breastfeeding.

A study of a small number of women with silicone gel breast implants found that the offspring born and breastfed after the mother had breast implants had higher levels of a toxic form of platinum in their blood than offspring born before the same women had breast implants. Problems with Memory and Concentration. Women with implants have raised concerns about memory loss, difficulties with concentration, and other cognitive problems.

Unfortunately, there is no well-designed published epidemiological research to determine whether there is an association between these complaints and breast implants. Financial Costs. Breast implant surgery is not a one-time cost.

On average, implants last years, and each replacement adds to the cost. Even if the implant itself is replaced for free, or if the surgeon offers his or her services for free, the cost of the medical facility, anesthesiology, and other expenses can still cost many thousands of dollars for each surgery.

These expenses are affordable for some women, but not for others, especially if the implant breaks after just a few months or years, or after a woman is divorced or loses her job. When the FDA approved silicone gel breast implants in November , it stated that women with these implants should have a breast MRI three years after getting silicone implants and every two years after that.

It is important to remove silicone implants if they are ruptured, to avoid the silicone leaking into the breast or lymph nodes. The cost of MRIs and the additional cost of removing leaking silicone makes silicone implants substantially more expensive than saline. What about health insurance? Typically, cosmetic surgery is not covered by health insurance, and problems resulting from cosmetic surgery are also not covered.

In some states, major health insurance providers do not insure women with breast implants. Obviously, this can be a terrible problem for women who are diagnosed with breast cancer or any other illnesses that are excluded, whether or not those diseases are related to the implants.

Women who have implants sometimes decide to have them removed because of complications, disappointment with how they look or feel, or concern about the long-term health risks.

Some surgeons discourage patients from removing their implants. If silicone has leaked into the breast tissue, the resulting removal surgery may be similar to a mastectomy. The plastic surgeon who performed the original surgery is not necessarily the best choice for removing the implant. Removal can be much more complicated and expensive than the original surgery, especially after a silicone gel implant has broken.

Some plastic surgeons are very experienced at removal and are especially skilled at getting the best possible cosmetic result. Since the shell and gel in these newer models are thicker than most other silicone gel implants, it is possible that they might be less likely to break or leak into the body. Only when the cohesive gel implants are in women for more than 10 years will we know whether and how the implant deteriorates or changes when it is in the human body.

Why long-term safety studies matter. In addition to silicone and saline implants, three other kinds of implants were developed and used primarily outside the United States: Trilucent implants with soybean oil filler , and Novagold and PIP hydrogel implants, which were filled with a plastic gel. They provide examples of why long-term safety studies are so important.

By , serious safety concerns resulted in the removal of all three from the market. That is why studies of the risks of long-term use — which are still lacking for silicone implants — are essential to establish the safety of all kinds of implants. Research clearly shows that implants are associated with significant health, cosmetic, and economic risks within the first few years and these risks increase over time.

Unfortunately, long-term risks remain unknown because of a lack of well-designed and carefully conducted scientific studies. Unfortunately, however, those studies were never completed and the FDA did not require the companies to substitute similarly well designed studies.

Because the body resorbs some of the injected fat grafts volume loss , compensative over-filling aids in obtaining a satisfactory breast outcome for the patient; thus the transplantation of large-volume fat grafts greater than required, because only 25—50 percent of the fat graft survives at 1-year post-transplantation. The surgical scars of a breast augmentation mammoplasty heal at 6-weeks post-operative, and fade within several months, according to the skin type of the woman. Newer Post Older Post Home. Moreover, to operate like real human limbs, or alongside real human limbs, robotic enhancements need a sensitive sense of touch. Yet those enhancements are coming, and some of the technology is here or nearly here. This is beginning on a small scale. Then, concatenate the original images with the augmented images and yield it.

History is augmentation on end

History is augmentation on end

History is augmentation on end

History is augmentation on end

History is augmentation on end. My eBook on Boobs!

The Cronin—Gerow implant, prosthesis model , was a silicone rubber envelope-sack, shaped like a teardrop, which was filled with viscous silicone-gel. To reduce the rotation of the emplaced breast-implant upon the chest wall, the model prosthesis was affixed to the implant pocket with a fastener-patch, made of Dacron material polyethylene terephthalate , which was attached to the rear of the breast implant shell.

In the s, manufacturers presented the second generation of breast implant prostheses that featured functional developments and aesthetic improvements to the technology:.

In the s, the models of the third and of the fourth generations of breast implant devices were sequential advances in manufacturing technology, such as elastomer -coated shells that decreased gel-bleed filler leakage , and a thicker increased-cohesion filler gel. Sociologically , the manufacturers of prosthetic breasts then designed and made anatomic models natural breast and shaped models round and tapered that realistically corresponded with the breast and body types of women.

The tapered models of breast implant have a uniformly textured surface, which reduces the rotation of the prosthesis within the implant pocket; the round models of breast implant are available in smooth-surface and textured-surface types.

Since the mids, the fifth generation of silicone-gel breast implant is made of a semi-solid gel that mostly eliminates the occurrences of filler leakage "silicone-gel bleed" and of the migration of the silicone filler from the implant-pocket to elsewhere in the woman's body.

The studies Experience with Anatomical Soft Cohesive Silicone gel Prosthesis in Cosmetic and Reconstructive Breast Implant Surgery and Cohesive Silicone gel Breast Implants in Aesthetic and Reconstructive Breast Surgery reported low incidence-rates of capsular contracture and of device-shell rupture; and greater rates of improved medical-safety and technical-efficacy than that of early generation breast-implant devices.

Saline and silicone gel are the most common type of breast implants used today. These types featured fillers such as soy oil and polypropylene string. Other discontinued materials include ox cartilage, Terylene wool, ground rubber, silastic rubber, and teflon-silicone prostheses. Structured implants were approved by the FDA and Health Canada in as a fourth form of breast implant.

The filler is only saline solution in case of rupture and has a natural feel like silicone gel implants. The implant is inserted empty and then filled once in place which requires less of an incision than pre-filled implants. The breasts are apocrine glands that produce milk for the feeding of infant children; each breast has a nipple within an areola nipple-areola complex, NAC , the skin color of which varies from pink to dark brown, and has sebaceous glands.

In each breast, 4—18 lactiferous ducts drain to the nipple; the glands-to-fat ratio is in lactating women, and in non-lactating women; besides milk glands, the breast is composed of connective tissue collagen , elastin , adipose tissue white fat , and the suspensory Cooper's ligaments.

The peripheral nervous system innervation of the breast is by the anterior and lateral cutaneous branches of the fourth, fifth, and sixth intercostal nerves , while the thoracic spinal nerve 4 T4 innervating the dermatomic area supplies sensation to the nipple-areola complex. Digestive contamination and systemic toxicity are the principal infant-health concerns; the leakage of breast implant filler to the breast milk, and if the filler is dangerous to the nursing infant.

Moreover, proponent physicians have said there "should be no absolute contraindication to breast-feeding by women with silicone breast implants. The woman with breast implants is able to breast-feed her infant; yet breast implant devices occasionally cause functional breast-feeding difficulties, especially the mammoplasty procedures that feature periareolar incisions and subglandular emplacement, which have greater incidences of breast-feeding difficulties.

Therefore, to ensure her breast-feeding functionality post-surgery, the woman of child-bearing age seeking breast implants discusses with her plastic surgeon the implantation procedure that will least damage her lactiferous ducts and the nerves of the nipple-areola complex NAC. Functional breast-feeding difficulties arise if the surgeon cut the milk ducts or the major nerves innervating the breast, or if the milk glands were otherwise damaged.

The milk glands are affected most by subglandular implants under the gland , and by large-sized breast implants, which pinch the lactiferous ducts and impede milk flow.

Small-sized breast implants, and submuscular implantation, cause fewer breast function problems; however, women have successfully breast-fed after undergoing periareolar incisions and subglandular emplacement.

The usual breast augmentation patient is a young woman whose personality profile indicates psychological distress about her personal appearance and her body self image , and a history of having endured criticism about the aesthetics of her person. Post-operative patient surveys about the mental health and the quality of life of the women, reported improved physical health, physical appearance, social life, self-confidence, self-esteem, and satisfactory sexual functioning.

Furthermore, most of the women reported long-term satisfaction with their breast implants; some despite having suffered medical complications that required surgical revision, either corrective or aesthetic.

Likewise, in Denmark, 8. The Cosmeticsurgery. Compared to the standard suicide-rate for women of the general populace, the suicide-rate for women with augmented breasts remained alike until years post-implantation, yet it increased to 4.

Moreover, additional to the suicide risk, women with breast implants also faced a trebled death risk from alcoholism and drugs abuse prescription and recreational. Moreover, the study Effect of Breast Augmentation Mammoplasty on Self-Esteem and Sexuality: A Quantitative Analysis , reported that the women attributed their improved self-esteem, self-image, and increased, satisfactory sexual functioning to having undergone breast augmentation; the cohort, aged 21—57 years, averaged post-operative self-esteem increases ranging from Therefore, before agreeing to any surgical procedure, the plastic surgeon evaluates and considers the woman's mental health to determine if breast implants can positively affect her self-esteem and sexual functioning.

An augmentation mammoplasty for emplacing breast implants has three therapeutic purposes:. The operating room time of post— mastectomy breast reconstruction , and of breast augmentation surgery is determined by the emplacement procedure employed, the type of incisional technique, the breast implant type and materials , and the pectoral locale of the implant pocket.

The emplacement of a breast implant device is performed with five types of surgical incisions: [42]. The four surgical approaches to emplacing a breast implant to the implant pocket are described in anatomical relation to the pectoralis major muscle.

The surgical scars of a breast augmentation mammoplasty heal at 6-weeks post-operative, and fade within several months, according to the skin type of the woman. Depending upon the daily physical activity the woman might require, the augmentation mammoplasty patient usually resumes her normal life activities at about 1-week post-operative.

The woman who underwent submuscular implantation beneath the pectoralis major muscles usually has a longer post—operative convalescence, and experiences more pain, because of the healing of the deep-tissue cuts into the chest muscles for the breast augmentation. The patient usually does not exercise or engage in strenuous physical activities for about six weeks.

Moreover, during the initial convalescence, the patient is encouraged to regularly exercise flex and move her arms to alleviate pain and discomfort; and, as required, analgesic medication catheters for alleviating pain. The plastic surgical emplacement of breast-implant devices, either for breast reconstruction or for aesthetic purpose , presents the same health risks common to surgery , such as adverse reaction to anesthesia , hematoma post-operative bleeding , seroma fluid accumulation , incision-site breakdown wound infection.

Because a breast implant is a Class III medical device of limited product-life, the principal rupture-rate factors are its age and design; Nonetheless, a breast implant device can retain its mechanical integrity for decades in a woman's body.

The follow-up report, Natrelle Saline-filled Breast Implants: a Prospective year Study indicated rupture-deflation rates of 3—5 percent at 3-years post-implantation, and 7—10 percent rupture-deflation rates at years post-implantation.

When a silicone breast implant ruptures it usually does not deflate, yet the filler gel does leak from it, which can migrate to the implant pocket; therefore, an intracapsular rupture in-capsule leak can become an extracapsular rupture out-of-capsule leak , and each occurrence is resolved by explantation.

Although the leaked silicone filler-gel can migrate from the chest tissues to elsewhere in the woman's body, most clinical complications are limited to the breast and armpit areas, usually manifested as granulomas inflammatory nodules and axillary lymphadenopathy enlarged lymph glands in the armpit area.

FDA's core clinical trials for primary breast augmentation surgery patients, reported low device-rupture rates of 1. The study, The Diagnosis of Silicone Breast-implant Rupture: Clinical Findings Compared with Findings at Magnetic Resonance Imaging , reported that, in asymptomatic patients, only 30 percent of the ruptured breast implants is accurately palpated and detected by an experienced plastic surgeon, whereas MRI examinations accurately detected 86 percent of breast-implant ruptures.

FDA recommended scheduled MRI examinations, as silent-rupture screenings, beginning at the 3-year-mark post-implantation, and then every two years, thereafter.

The longer a woman has silicone gel-filled breast implants, the more likely she is to experience complications. When one lumen of a structured implant ruptures, it leaks and empties. The other lumen remain intact and the implant only partially deflates, allowing for ease of explant and replacement. The cause of capsular contracture is unknown, but the common incidence factors include bacterial contamination, device-shell rupture, filler leakage, and hematoma.

The surgical implantation procedures that have reduced the incidence of capsular contracture include submuscular emplacement, the use of breast implants with a textured surface polyurethane-coated ; [69] [70] [71] limited pre-operative handling of the implants, limited contact with the chest skin of the implant pocket before the emplacement of the breast implant, and irrigation of the recipient site with triple-antibiotic solutions.

The correction of capsular contracture might require an open capsulotomy surgical release of the collagen-fiber capsule, or the removal, and possible replacement, of the breast implant. Furthermore, in treating capsular contracture, the closed capsulotomy disruption via external manipulation once was a common maneuver for treating hard capsules, but now is a discouraged technique, because it can rupture the breast implant.

Non-surgical treatments for collagen-fiber capsules include massage, external ultrasonic therapy, leukotriene pathway inhibitors such as zafirlukast Accolate or montelukast Singulair , and pulsed electromagnetic field therapy PEMFT. When the woman is unsatisfied with the outcome of the augmentation mammoplasty; or when technical or medical complications occur; or because of the breast implants' limited product life Class III medical device , in the U.

The common revision surgery indications include major and minor medical complications, capsular contracture , shell rupture, and device deflation. Carefully matching the type and size of the breast implants to the patient's pectoral soft-tissue characteristics reduces the incidence of revision surgery. Appropriate tissue matching, implant selection, and proper implantation technique, the re-operation rate was 3.

Food and Drug Administration. Since the s, reviews of the studies that sought causal links between silicone-gel breast implants and systemic disease reported no link between the implants and subsequent systemic and autoimmune diseases.

In the study Long-term Health Status of Danish Women with Silicone Breast Implants , the national healthcare system of Denmark reported that women with implants did not risk a greater incidence and diagnosis of autoimmune disease , when compared to same-age women in the general population; that the incidence of musculoskeletal disease was lower among women with breast implants than among women who had undergone other types of cosmetic surgery; and that they had a lower incidence rate than like women in the general population.

Follow-up longitudinal studies of these breast implant patients confirmed the previous findings on the matter.

Moreover, because only one study, the Swedish Long-term Cancer Risk Among Swedish Women with Cosmetic Breast Implants: an Update of a Nationwide Study , controlled for tobacco smoking information, the data were insufficient to establish verifiable statistical differences between smokers and non-smokers that might contribute to the higher lung cancer mortality rate of women with breast implants.

The study Silicone gel Breast Implant Rupture, Extracapsular Silicone, and Health Status in a Population of Women , reported increased incidences of fibromyalgia among women who suffered extracapsular silicone-gel leakage than among women whose breast implants neither ruptured nor leaked. After investigating, the U. FDA has concluded "the weight of the epidemiological evidence published in the literature does not support an association between fibromyalgia and breast implants.

The manufacture of silicone breast implants requires the metallic element Platinum Pt. The rare pathogenic consequence is an accumulation of platinum in the bone marrow , from where blood cells might deliver it to nerve endings , thus causing nervous system disorders such as blindness, deafness, and nervous tics involuntary muscle contractions.

In , the U. Food and Drug Administration U. FDA reviewed the studies on the human biological effects of breast-implant platinum, and reported little causal evidence of platinum toxicity to women with breast implants. FDA reported that the data do not support the findings presented; that the platinum used, in new-model breast implant devices, likely is not ionized , and therefore is not a significant risk to the health of the women. The operating room OR time of breast reconstruction, congenital defect correction, and primary breast augmentation procedures is determined by the indications to be treated.

The advent of liposuction technology facilitated medical applications of the liposuction-harvested fat tissue as autologous filler for injection to correct bodily defects, and for breast augmentation.

Melvin Bircoll introduced the practice of contouring the breast and for correcting bodily defects with autologous fat grafts harvested by liposuction; and he presented the fat-injection method used for emplacing the fat grafts. To emplace the grafts of autologous fat-tissue, doctors J. Newman and J.

Levin designed a lipo-injector gun with a gear-driven plunger, which allowed the even injection of autologous fat-tissue to the desired recipient sites. The control afforded by the lipo-injector gun assisted the plastic surgeon in controlling excessive pressure to the fat in the barrel of the syringe, thus avoiding over-filling the recipient site.

The technique of autologous fat-graft injection to the breast is applied for the correction of breast asymmetry; of breast deformities; for post-mastectomy breast reconstruction as a primary and as an adjunct technique ; for the improvement of soft-tissue coverage of breast implants; and for the aesthetic enhancement of the bust. The careful harvesting and centrifugal refinement of the mature adipocyte tissue injected in small aliquots allows the transplanted fat tissue to remain viable in the breast, where it provides the anatomical structure and the hemispheric contour that cannot be achieved solely with breast implants or with corrective plastic surgery.

In fat-graft breast augmentation procedures, there is the risk that the adipocyte tissue grafted to the breast s can undergo necrosis , metastatic calcification , develop cysts, and agglomerate into palpable lumps. Although the cause of metastatic calcification is unknown, the post-procedure biological changes occurred to the fat-graft tissue resemble the tissue changes usual to breast surgery procedures such as reduction mammoplasty.

The French study Radiological Evaluation of Breasts Reconstructed with Lipo-modeling indicates the therapeutic efficacy of fat-graft breast reconstruction in the treatment of radiation therapy damage to the chest, the incidental reduction of capsular contracture , and the improved soft-tissue coverage of breast implants. The study Fat Grafting to the Breast Revisited: Safety and Efficacy reported successful transferences of body fat to the breast , and proposed the fat-graft injection technique as an alternative non-implant augmentation mammoplasty procedure instead of the surgical procedures usual for effecting breast augmentation, breast defect correction, and breast reconstruction.

In a patient cohort, two women had breast cancer diagnosed by mammogram one at months post-procedure, and the other at months post-procedure. In contemporary surgical praxis, to realize the required correction, aside from the breast proper, fat grafts are injected to the pectoralis major muscle , to the postpectoral space and to the prepectoral space, before and behind said muscle.

In post-mastectomy breast reconstruction, the grafted fat is used to create a breast mound, by augmenting the extant breast tissues that remained after the surgical removal of the cancerous breast. Structural fat-grafting was performed either to one breast or to both breasts of the 17 women; the age range of the women was 25—55 years, and the mean age was The women of the study cohort presented clinical indications such as micromastia 10 patients ; explantation deformity one patient ; post-augmentation deformity, with breast implants two patients ; tuberous breast deformity one patient ; Poland's syndrome one patient ; and post-mastectomy reconstruction deformity two patients.

The pre-procedure mammograms were negative for malignant neoplasms. The types of anaesthesia applied were general two patients and epidural analgesia plus sedation, with local infiltration and intercostal nerve blocks 15 patients. The autologous adipocyte tissue was grafted in one-to-three stages; the average volume of a tissue-graft was Post-procedure, each patient was instructed to regard any lump in the breasts as unrelated to the fat grafts, until after a complete medical workup of the breast lump had been performed.

The centrifugal refinement of the liposuction-harvested adipocyte tissues removes blood products and free lipids to produce autologous breast filler. The injectable filler-fat is obtained by centrifuging spinning the fat-filled syringes for sufficient time to allow the serum, blood, and oil liquid fat components to collect, by density, apart from the refined, injection-quality fat.

Furthermore, because the patient's body naturally absorbs some of the fat grafts, the breasts maintain their contours and volumes for 18—24 months.

In the study Fat Grafting to the Breast Revisited: Safety and Efficacy , the investigators reported that the autologous fat was harvested by liposuction, using a ml syringe attached to a two-hole Coleman harvesting cannula ; after centrifugation, the refined breast filler fat was transferred to 3-ml syringes.

Blunt infiltration cannulas were used to emplace the fat through 2-mm incisions; the blunt cannula injection method allowed greater dispersion of small aliquots equal measures of fat, and reduced the possibility of intravascular fat injection; no sharp needles are used for fat-graft injection to the breasts.

The 2-mm incisions were positioned to allow the infiltration emplacement of fat grafts from at least two directions; a 0. The breasts were contoured by layering the fat grafts into different levels within the breast, until achieving the desired breast form.

This greater degree of breast sculpting is unlike the global augmentation realised with a breast implant emplaced below the breast or below the pectoralis major muscle, respectively expanding the retromammary space and the retropectoral space.

The greatest proportion of the grafted fat usually is infiltrated to the pectoralis major muscle, then to the retropectoral space, and to the prepectoral space, before and behind the pectoralis major muscle. Moreover, although fat grafting to the breast parenchyma usually is minimal, it is performed to increase the degree of projection of the bust. The biologic survival of autologous fat tissue depends upon the correct handling of the fat graft, of its careful washing refinement to remove extraneous blood cells, and of the controlled, blunt-cannula injection emplacement of the refined fat-tissue grafts to an adequately vascularized recipient site.

Because the body resorbs some of the injected fat grafts volume loss , compensative over-filling aids in obtaining a satisfactory breast outcome for the patient; thus the transplantation of large-volume fat grafts greater than required, because only 25—50 percent of the fat graft survives at 1-year post-transplantation. The correct technique maximizes fat graft survival by minimizing cellular trauma during the liposuction harvesting and the centrifugal refinement, and by injecting the fat in small aliquots equal measures , not clumps too-large measures.

Injecting minimal-volume aliquots with each pass of the cannula maximizes the surface area contact, between the grafted fat-tissue and the recipient breast-tissue, because proximity to a vascular system blood supply encourages histologic survival and minimizes the potential for fat necrosis. New fat tissue is generated by the activity of a large, wandering histocyte -type cell , which ingests fat and then becomes a fat cell. The technique for injecting fat grafts for breast augmentation allows the plastic surgeon great control in sculpting the breasts to the required contour, especially in the correction of tuberous breast deformity.

In which case, no fat-graft is emplaced beneath the nipple-areola complex NAC , and the skin envelope of the breast is selectively expanded contoured with subcutaneously emplaced body-fat, immediately beneath the skin.

Such controlled contouring selectively increased the proportional volume of the breast in relation to the size of the nipple-areola complex, and thus created a breast of natural form and appearance; greater verisimilitude than is achieved solely with breast implants. The fat-corrected, breast-implant deformities, were inadequate soft-tissue coverage of the implant s and capsular contracture , achieved with subcutaneous fat-grafts that hid the implant-device edges and wrinkles, and decreased the palpability of the underlying breast implant.

Furthermore, grafting autologous fat around the breast implant can result in softening the breast capsule. The successful outcome of fat-graft breast augmentation is enhanced by achieving a pre-expanded recipient site to create the breast-tissue matrix that will receive grafts of autologous adipocyte fat. The recipient site is expanded with an external vacuum tissue-expander applied upon each breast.

The biological effect of negative pressure vacuum expansion upon soft tissues derives from the ability of soft tissues to grow when subjected to controlled, distractive, mechanical forces. In a single-group study, 17 healthy women aged 18—40 years wore a brassiere-like vacuum system that applied a mmHg vacuum controlled, mechanical, distraction force to each breast for 10—12 hours daily for 10 weeks.

Pre- and post-procedure, the breast volume size was periodically measured; likewise, a magnetic resonance image MRI of the breast-tissue architecture and water density was taken during the same phase of the patient's menstrual cycle ; of the woman study group, 12 completed the study, and 5 withdrew, because of non-compliance with the clinical trial protocol.

Incidences of partial recoil occurred at 1-week post-procedure, with no further, significant, breast volume decrease afterwards, nor at the follow-up treatment at weeks post-procedure.

The MRI visualizations of the breasts showed no edema , and confirmed the proportionate enlargement of the adipose and glandular components of the breast-tissue matrices.

Furthermore, a statistically significant decrease in body weight occurred during the study, and self-esteem questionnaire scores improved from the initial-measure scores. The long-term, volume maintenance data reported in Breast Augmentation using Pre-expansion and Autologous Fat Transplantation: a Clinical Radiological Study indicate the technical effectiveness of external tissue expansion of the recipient site for a patient study group, who had 46 breasts augmented with fat grafts.

The indications included micromastia underdevelopment , explantation deformity empty implant pocket , and congenital defects tuberous breast deformity , Poland's syndrome. Nice bra mobogenie descargar , descargar whatsapp plus gratis , descargar whatsapp plus gratis , coolmath4kids. Breast augmentation is done by placing implants behind breast tissue or under the chest muscle.

Great Post,Breast augmentation is the scientific term for breast implant surgery. This surgery can improve the size and shape of your breast. Breast Implants Jerusalem. Breast implant is popular since long, people are aware of it for implantation, reduction, lift.

One of the cosmetic surgery to resize the breast of womens for better physical appearance. Breast Implant Surgery.

Thanks for sharing such an informative and useful post. Breast Augmentation in Dubai is right choice for smaller and uneven breasts. Breast augmentation , sometimes referred to as a 'boob job' by patients, involves using breast implants or fat transfer to increase the size of your breasts.

Learn about breast augmentation, implants cost, surgeon in India. You can book your appointment with Dr. Breast augmentation surgery is very beneficial for those women who want to reshape or resize their breast shape. Get the surgery from expert cosmetic surgeon to have realistic results Best breast augmentation in kolkata Breast reduction surgery in kolkata Best breast enlargement surgery in kolkata Best Liposuction in Kolkata.

Prostate cancers usually progress slowly and produce no symptoms in the initial stages. Eventually, the tumor may enlarge like mine use too, the prostate gland, pressing on the urethra and causing painful or frequent urination and blood in the urine. I contacted Dr Itua that i have received my herbal medicine so he instructs me on how to drink it for three weeks and that is how Dr Itua Herbal Medicine cure my prostate Cancer, The treatment takes three weeks and I was cured completely.

Dr Itua is a god sent and I thank him every day of my life. Contact him now On:Email:drituaherbalcenter gmail. He listed to that he can as well cure the following diseases below Cerebral Amides. Lung Cancer, Alzheimer's disease, Adrenocortical carcinoma. Kidney cancer, Love Spell, Glaucoma. Enlarged prostate,Osteoporosis. Alzheimer's disease, Dementia. Liposuction Treatment Cosmetic Clinic in Karachi.

Breast Implants - A History. Breast augmentation is not only about getting implants - patients undergo breast reductions as well as enlargements, with common reasons ranging from backache to fears about breast cancer, to purely cosmetic concerns. Modern-day techniques are minimally invasive, allowing implants to be put in place safely, while reductions are also carried out with the aim of leaving minimal scarring behind, even in complicated procedures where large amounts of tissue are removed and the nipple repositioned.

Whether you are having an enlargement or a reduction, centuries of progress are behind the approach taken by your surgeon - and breast augmentation has made rapid progress in the past 50 years alone.

While forms of plastic surgery have been around for centuries, and breast implants made of sponge and other materials had already been attempted, it wasn't until that the first silicone implants were devised by Texan doctors Frank Gerow and Thomas Cronin. Timmie Jean Lindsey became the first human recipient - and made headlines again 50 years later when, at the age of 80, she appeared in newspapers around the world to comment on the 50th anniversary of silicone implants. Lindsey was pictured within weeks of her operation and, while the images are low-resolution, they demonstrate that her healing process had seemingly taken about two months to complete.

In the s, mass-production of breast implants gathered speed, and new alternatives were introduced - including attempts at creating inflatable implants.

However, it was progress in silicone implants that led the industry throughout the decade, with much softer outer casings better mimicking real breast tissue. Safety became a key concern in the s amidst claims that silicone implants could cause health problems.

Leakage of the silicone gel through the thin walls of the implants used at the time was linked with cancer in animals, but no equivalent risk was found in humans, and by the end of the decade new implants with thicker walls were being introduced. Regulations in the US dominated the decade, as the FDA announced a voluntary moratorium on the use of silicone implants in January , until further safety investigations had been carried out. From July , silicone implants were approved for reconstruction work, while June saw approval given for limited augmentation work with silicone implants.

According to the American Society for Aesthetic Plastic Surgery ASAPS , , breast augmentations were carried out in - remember that figure, as we'll be coming back to it later. By the end of the decade, breast augmentation was by far the most popular form of cosmetic surgery, but ASAPS figures show that it has its rivals.

From , breast augmentations carried out in the US in , the figure rose to , in - but for the first time in three years, liposuction ranked as the top US cosmetic surgical procedure, with , individual procedures carried out. Today there are all sorts of breast augmentation procedures carried out on a daily basis - from simple implants or reductions, to mastopexy breast uplift surgery which restores a more youthful appearance, and male reductions to tackle gynaecomastia.

Professional organisations such as BAAPS exist to ensure standards are upheld - and are as likely to be seen campaigning against unsafe procedures as they are to be championing the latest innovation.

Breast augmentation is here to stay, whether carried out on the NHS for purely health-related reasons, or privately for cosmetic purposes - and in both instances, there is a real commitment to patient care and to providing implants that can remain in place for many years to come.

Posted by Grace Gold at PM. Samantha September 24, at AM. Anonymous September 25, at AM. Flory September 26, at AM. Breast augmentation surgery September 27, at AM. Larry Williams September 28, at AM. Anne Tan September 28, at AM.

Anonymous October 9, at AM. Sri Ram October 12, at AM. Breast Augmentations October 27, at AM. Anonymous December 5, at AM. Anonymous December 5, at PM. Breast Augmentations December 7, at AM. Fat Reduction December 10, at AM. Anonymous December 19, at AM.

Salon January 2, at AM. Breast augmentation surgeon January 23, at AM. Unknown February 18, at AM. Shavonda Duarte February 22, at PM. Jess Toons March 19, at PM. Unknown April 12, at AM. Emmanuel Asare April 17, at PM. AmdelInfo ways April 18, at AM. Anonymous May 27, at AM. Jerry Dewi June 12, at PM. Anonymous June 25, at AM. Bobby Smith July 26, at AM. Phillip Mullennax August 22, at AM. Farhat Bukhari January 22, at AM.

Breast Augmentation March 29, at PM. Elina Mark April 21, at AM. Breast Augmentation August 26, at AM. Zeda Jackson September 11, at PM. Mia Hart October 8, at PM. Seyma Sheik November 18, at AM. Marcus Morgan December 4, at PM. Joseph Cauley December 8, at AM. Cynthia Rhose December 8, at AM. Kelsey Compars March 5, at PM. Ashmita February 12, at AM.

Divya Patil February 13, at AM. Riya Sharma June 24, at AM. Nehal umber July 9, at AM. Eshmaal Fatin April 25, at AM. Preeti Joshi May 19, at AM. Medspa Clinic June 15, at AM. Unknown June 2, at AM. Charlotte Thomas June 14, at PM. Sohail Hussain August 3, at AM. Newer Post Older Post Home. Subscribe to: Post Comments Atom.

Meet Grace Gold Visit Grace's homepage. My eBook on Boobs! Considering a breast augmentation? Don't miss this - get my FREE report emailed to you immediately! Name Email. Her experience ranges the gamut from covering backstage beauty at over New York Fashion Week shows, to interviewing A-list celebrities and leading aesthetic experts, to authoring a book on breast augmentation. You can connect with Grace at www.

View my complete profile. You Can Use My Posts! If you'd love to use one of my posts in your newsletter, blog or website - you have my permission under one condition!

Search This Blog.

[] Back-Translation-Style Data Augmentation for End-to-End ASR

Capsular contracture is the most common complication following implant based breast surgery and is one of the most common reasons for reoperation. Therefore, it is important to try and understand why this happens, and what can be done to reduce its incidence. A literature search using the MEDLINE database was conducted including search terms 'capsular contracture breast augmentation', 'capsular contracture pathogenesis', 'capsular contracture incidence', and 'capsular contracture management', which yielded 82 results which met inclusion criteria.

Capsular contracture is caused by an excessive fibrotic reaction to a foreign body the implant and has an overall incidence of Risk factors that were identified included the use of smooth vs. The standard management of capsular contracture is surgical via a capsulectomy or capsulotomy. Medical treatment using the off-label leukotriene receptor antagonist Zafirlukast has been reported to reduce severity and help prevent capsular contracture from forming, as has the use of acellular dermal matrices, botox and neopocket formation.

However, nearly all therapeutic approaches are associated with a significant rate of recurrence. Capsular contracture is a multifactorial fibrotic process the precise cause of which is still unknown. The incidence of contracture developing is lower with the use of textured implants, submuscular placement and the use of polyurethane coated implants.

Symptomatic capsular contracture is usually managed surgically, however recent research has focussed on preventing capsular contracture from occurring, or treating it with autologous fat transfer.

Breast augmentation is one of the most commonly performed cosmetic procedures [ 1 ]. This commonly involves an implant being inserted within the breast in order to alter the shape and size of the breast. Various types of implant are available and they are generally divided according to the shape of the implant whether rounded or anatomically shaped , or the surface texture whether smooth or textured or the gel used to fill the implant usually either saline or silicone [ 2 ].

Silicone breast implants are currently the most popular and accepted material for use in breast augmentation. These can take one of two forms: a silicone outer shell with a silicone gel filling, or a silicone outer shell with an alternative filling, such as saline [ 3 ].

However, the general consensus is that the postsurgical mechanical behaviour of silicone implants is more like natural breast tissue when compared to saline [ 4 ]. As with any surgery, implant based breast augmentation has been associated with a number of risks and complications.

The most common complication is capsular contracture as identified in a 25 years longitudinal study by Handel et al. Introduction of non-biologic materials into the body always induces formation of a capsule, but in the breast this may be particularly severe. Capsular contracture is a local complication thought to occur due to an excessive fibrotic foreign body reaction to the implant. It is thought to be an inflammatory reaction which causes fibrosis through the production of collagen [ 3 ], leading to excessively firm and painful breasts [ 6 ].

If severe enough, this can require reoperation [ 7 ]. For an example of how capsular contracture may present Fig. This is a picture of a year-old woman who has Baker grade IV capsular contracture. On the left, the breast is noticeably higher and there is noticeable skin puckering along the medial side.

The nipple is higher relative to the right side. Capsular contracture is traditionally classified using the Baker classification system, a subjective classification system that is based upon clinical findings in the patient by the physician.

It is divided into four classes: I and II are not clinically significant, in that I describes a breast that looks and feels absolutely natural and II describes a breast with minimal contracture in that the surgeon can tell surgery has been performed but there are no symptoms.

Class III and IV are clinically significant and symptomatic, with III describing moderate contracture with some firmness felt by the patient and IV describing severe contracture which is obvious from observation and symptomatic in the patient [ 8 ]. Individual studies have published incidence rates of capsular contracture ranging from 2.

A recent systematic review published a combined overall rate of 3. However, there is a wide range of heterogeneity between studies in terms of follow up times which may affect capsular contracture development rates, as well as a lack of standardisation in the type of implant and surgical techniques used. The individual study variables are outlined in Table 1.

Despite the wide range of incidence rates reported, it is widely accepted that capsular contracture is the most common complication following implant based breast surgery. Despite this, the aetiology and pathogenesis is not yet clear, although it appears to be multifactorial. In order to effectively treat, or even prevent capsular contracture, it is important to understand the mechanisms that lead to it.

The aim of this paper is to review the current literature available in order to look at the pathogenesis, the risk factors and the optimal management of capsular contracture following breast augmentation surgery.

The pathogenesis of capsular contracture is thought to be multifactorial. It is known that capsular contracture is essentially an excessive fibrotic foreign body reaction that occurs after implantation [ 6 , 15 ]. Whist on the one hand, this fibrotic reaction helps to maintain the position of the implant, if excessive it can lead to pain and deformity of the breast [ 16 ]. The cellular composition of the capsule has been studied extensively, and the results seem to suggest a role of the immune system in the pathogenesis of capsular contracture.

Macrophages, lymphocytes and fibroblasts have been reported to be the predominant cell types within the capsule. Fibroblasts accumulate at the 'contact zone' of the implant and the capsule [ 6 , 17 , 18 ], and it has been reported that the number of fibroblasts within the capsule correlates with the Baker grade, with an increased number found in grade IV capsular contracture when compared to grade I [ 19 ]. As fibroblasts produce collagen, they have been linked to the initial formation of the capsule.

Histological evaluation of capsular tissue has shown that the majority of the tissue is made up of uniformly distributed collagen fibres [ 3 , 19 ]. The orientation and organisation of the collagen fibres appears to change as contracture severity worsens: the fibres become thicker and establish themselves in cable-like bundles which orientate themselves perpendicular to the fibroblasts to produce a helical orientation as the severity increases [ 20 ].

The fibroblasts in turn orientate themselves planarly when studied in capsules surrounding smooth implants [ 16 ]. Mast cells have also been investigated with regards to their involvement in the pathogenesis of capsular contracture. Additionally, capsular fibroblasts express corresponding receptors, indicating that the mast cells may activate neighbouring fibroblasts via a paracrine pathway following mast cell degranulation, leading to increased production of collagen and therefore development of capsule contracture.

The role of myofibroblasts in the development of capsule contracture has also been investigated. Myofibroblasts are contractile fibroblasts which are thought to provide a contractile force which decreases the surface area of the capsule whilst the collagen matrix remodels and stabilises the contracture. In the same study, Persichetti et al. Therefore, anti-oestrogenic therapy may help reduce the severity or perhaps prevent capsular contraction from developing.

A role of T cells has also been hypothesised. Despite knowing the cells that appear to involved in the process of capsular contracture, it is important to know the way in which they are activated in order to understand how exactly it develops and thus develop strategies to try and prevent it. Similarly, MMP-2 expression is significantly increased with more severe grades of Baker classification, with a reduced ratio of MMP to TIMP, a similar scenario as observed in other progressive fibrotic disorders [ 26 ].

A recent study by Katzel et al. In mice with a knock out of this signalling pathway, capsules were thinner and more regular after being exposed to radiotherapy when compared to controls, which showed thicker capsules made up or irregular collagen. Other immunological agents have also been reported as having a role in the development of capsular contracture. These include connective tissue growth factor factor and interleukins 4, 6, 10, 13, and 21 amongst others, all of which promote fibrosis [ 30 ].

However, more research on their individual roles needs to be conducted before their influence can be fully evaluated. Interleukin-8 has been suggested as a potential biomarker after Kyle et al. This is not the only molecule that has been discussed as a potential biomarker. Wolfram et al. Although the majority of current evidence appears to support the role of the immune system, historically it has been suggested that capsular contracture may result from an exaggerated inflammatory response caused by a haematoma or infection.

A number of studies have found that the presence of bacteria accelerates contracture development in animal models [ 33 , 34 ]. In particular, the role of coagulase negative staphylococcus species has been investigated with some interest, with a lot of focus on involvement of Staphylococcus epidermidis , where its presence on implants in animal models has been found to cause increased capsule pressure and a thicker capsule that has an increased density of collagen and increased angiogenesis, all of which are subsequently associated with capsular contracture [ 33 ].

However, this theory fails to take into account a number of variables. Firstly, capsular contracture does not affect every patient; therefore it is likely that phenotype plays a part in the reaction. Also, this theory fails to take into account the time lapse often present between surgery and clinically significant contracture development, which can vary greatly.

Additionally, prophylactic strategies such as antibiotic irrigation have failed to show any difference in capsular contracture rates, with reports that washing the implants antispetcially or giving systemic antibiotics having only minor effects, if any [ 16 ].

In one study, triple antibiotic breast irrigation was found not to be associated with a significant reduction in the severity of capsular contracture, with rates published at 3.

Additionally, in a porcine experiment, animals which were given implants and inoculated with S. This indicates that infection, and the subsequent inflammatory response, whilst maybe increasing the rate at which capsular contracture develops does not in fact cause it. There is a wide variety of implants that are available for implant based breast surgery, each of which have slightly different properties.

These can be broadly separated into whether the surface of the implant is smooth or textured, or whether they are filled with silicone gel or saline and whether the implants are rounded or anatomically shaped.

A number of companies provide and develop breast implants, two of the most widely used being Allergan Allergan Inc. Patients tend to be consulted on the type of implant they would prefer, be that silicone based or saline based, so therefore it is important to understand the risks associated with each in order to allow fully informed consent.

Silicone gel implants, first introduced in , currently dominate the world market and this is reflected in the much larger range available for use [ 36 ]. In the past, there were concerns with the use of silicone gel implants, especially in the United States of America where their use was restricted to clinical trials up until due to safety concerns. However, long term studies assessing their safety are currently underway. In terms of the Allergan models, there is both rounded and shaped implants available.

A long term multicentre clinical trial is currently underway assessing the Natrelle Style implant, a form stable highly cohesive shaped model. Results from 3 years reported a capsular contracture rate of 4. A further study reported a 5. A similar study looking at shaped Mentor silicone implants reported a 2.

Therefore, both suppliers have acceptably low capsular contracture rates with silicone models and the long term results of these multicentre trials are likely to have interesting findings. Silicone as a filler material has a number of advantages: it is thought that the implants act more like natural breast tissue and due to extensive development of silicone implants are more technologically innovated. However, saline is still an option for patients. Saline implants also offer a number of advantages.

The main advantage is that saline implants sidestep concerns regarding rupture of silicone implants. If saline implants rupture, the fluid is absorbed harmlessly into the body, however exposure to silicone gel is thought to be more dangerous [ 36 ]. There is less variety available with saline implants and they have remained relatively unchanged over the last few years. In terms of capsular contracture risk, a ten year prospective study of the Allergan Natrelle saline filled implants found a This is in contract to a meta-analysis carried out in which reported a greater than two-fold increased risk of capsular contracture following treatment with silicone gel implants as opposed to saline.

However, these results were limited by the poor scientific qualities of the studies involved and a high variability of the different types of implant used in the various studies [ 43 ]. Ideally, more research comparing long term use of saline and silicone implants would be useful or an updated meta-analysis which includes the results of the studies mentioned above in order to evaluate any potential difference in capsular contracture risk.

The surface texture of the implant has also been found to have an effect on the incidence of capsular contracture.

History is augmentation on end

History is augmentation on end